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CASE REPORT
A viable caesarean scar pregnancy in a woman using a
levonorgestrel-releasing intrauterine device: a case report
Emilie Hitzerda, Hein Bogersa, Noush A. Kianmanesh Radb and Johannes J. Duvekota
aDepartment of Obstetrics and Gynaecology, Erasmus MC University Medical Center, Rotterdam, The Netherlands; bDepartment of
Obstetrics and Gynaecology, IJsselland Hospital, Capelle aan den IJssel, The Netherlands
ABSTRACT
Background: Although the levonorgestrel-releasing intrauterine device (LNG-IUD) is one of the
most reliable methods of contraception, it is associated with an increased risk of ectopic pregnancy
in case of unintended pregnancy. A rare form of ectopic pregnancy is the caesarean scar pregnancy
(CSP), with a high risk of serious maternal morbidity, such as uterine rupture, massive haemorrhage
and resulting infertility. This report describes the first case of a viable CSP at 13 weeks of gestation
in association with the use of a LNG-IUD.
Case-presentation: A 36-year-old Caucasian woman was referred to our outpatient clinic because
of suspicion of a CSP. The pregnancy was unintended and was diagnosed during replacement of
the LNG-IUD after five years. The patient had undergone two caesarean sections in the past.
Ultrasound investigation showed an intact pregnancy of approximately 13 weeks of gestation
located in the uterine scar. Because of the size of the gestational sac, a laparotomy was performed
under general anaesthesia using a Joel-Cohen incision. The procedure was complicated by a total
blood loss of 1500mL, mostly caused by diffuse bleeding from the placental bed.
Conclusion: Unintended pregnancies in women using a LNG-IUD are frequently ectopic pregnan-
cies with a preponderance to nidate outside the fallopian tube. Therefore, early diagnosis and loca-
tion of the pregnancy in women using a LNG-IUD is essential.
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When properly situated, the levonorgestrel-releasing intra-
uterine device (LNG-IUD, MirenaVR ) is one of the most reli-
able forms of reversible contraception, with a pregnancy
rate of less than 0.1% and a Pearl index of 0.06 [1,2].
The LNG-IUD is a plastic T-shaped device with the vertical
stem containing a reservoir of 52mg levonorgestrel and
a polydimethylsiloxane elastomer mixture, covered by a
polydimethylsiloxane membrane, which acts as a rate-limit-
ing membrane releasing 20mcg of levonorgestrel per
24 hours.
It is well-known that the use of an intra-uterine contra-
ceptive increases the chance of an ectopic pregnancy [1].
However, in case of an unintended pregnancy, the chance
of an ectopic pregnancy with an LNG-IUD is slightly higher
than with copper IUDs [2]. Most of these pregnancies are
located in the fallopian tube, but also in the ovary, the cor-
neal part of the tube and the cervix. The most rare form of
ectopic pregnancy is the caesarean scar pregnancy (CSP)
[3,4]. Although rare, CSP can lead to serious complications
such as uterine rupture or catastrophic haemorrhage, with
a high risk of hysterectomy and even sometimes leading to
maternal death [5,6].
We are the first to present a case of a vital CSP of 13
weeks of gestation in combination with a LNG-IUD.
Case presentation
A 36-year-old Caucasian woman was referred to our out-
patient clinic because of suspicion of a CSP. The pregnancy
was unintended and was diagnosed during replacement of
the LNG-IUD after five years. After replacement, the patient
started bleeding excessively and an intact pregnancy was
discovered on ultrasound. Beforehand, the patient had not
experienced any abdominal symptoms or vaginal bleeding.
The LNG-IUD was removed and the patient was referred.
Her obstetrical history reported twice a caesarean section.
Her further medical history was uneventful.
Ultrasound investigation showed an intact pregnancy of
approximately 13 weeks of gestation (based on a biparietal
diameter of 24mm) located in the uterine scar. The pla-
centa was located posteriorly.
After consultation with the patient, it was decided to
evacuate the pregnancy. Because of the size of the gesta-
tional sac, a laparotomy was performed under general
anaesthesia, using a Joel-Cohen incision. The gestational
sac could already be visualized through the very thin, trans-
lucent uterine wall. An incision in the uterus was made cra-
nial to this, and the fetus and placenta were removed. The
margins of the uterine incision were excised to ensure com-
plete removal of all pregnancy tissue and the uterus was
closed in a single layer. Afterwards, tubal sterilization with
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Filshie clips was performed. The procedure was compli-
cated by a total blood loss of 1500mL, mostly caused by
diffuse bleeding from the placental bed. The removed
pregnancy tissue was sent for histological analysis, which
showed a fetus without dysmorphic features and a normal
placenta. After two days the patient was discharged from
the hospital in good clinical condition.
Six weeks after the surgery, the patient revisited the out-
patient clinic. Further recovery had been uneventful.
Transvaginal ultrasound showed hardly any remaining
dehiscence of the uterine scar (Figure 1).
Discussion
The LNG-IUD has the lowest failure rate of the reversible
contraceptive measures, with reported Pearl indices rang-
ing from 0.1 to 0.6 and ectopic pregnancy rates ranging
from 0.02 to 0.2 [1,2]. Causes of failure include unnoticed
expulsion and dislocation of the device (not in the uterine
cavity). Even when located in the cervix the device works
and seems reliable [7], but in some cases pregnancy occurs
despite adequate localization. In the latter cases, the rela-
tive risk of an ectopic pregnancy increases dramatically.
In one prospective cohort study, 27% of all unintended
pregnancies were ectopic [2]. Other studies report even
higher ectopic pregnancy rates up to 50% [7–9]. Although
most of these ectopic pregnancies are located in the fallo-
pian tube, a larger percentage than usual seems located in
the ovary, the corneal part of the tube or the cervix. So
far, besides of tubal pregnancies, two cervical pregnancies,
one cornual pregnancy and especially many ovarian preg-
nancies have been described in literature [10–12]. The pre-
ponderance of these aberrant locations in case of
unintended pregnancy in combination with a LNG-IUD
may be found in the working mechanism of this device.
The contraceptive effect is most probably due to local
endometrial suppression, thickening of the cervical mucus
and alteration of uterotubal fluid, as well as suppression of
ovarian function in some women. This makes it more likely
that nidation may take place outside the endometrium
and the fallopian tube.
The rarest form of ectopic pregnancy is the caesarean
scar pregnancy (CSP), occurring in 1:1800 to 1:2226 of all
pregnancies [3,4]. Little is known about the exact aetiology,
however, it is thought that CSP occurs when a blastocyst
implants on fibrous tissue within a wedge-shaped
myometrial defect at the site of a prior caesarean scar [13].
So far, only one CSP was described in combination with
LNG-IUD use [14]. This pregnancy was terminated by med-
ical treatment with methotrexate and leucovorin at five
weeks of gestation, also because there was a heterotopic
intrauterine pregnancy.
The first case of CSP was already reported in 1978, but
over the past ten years there has been a significant rise in
the number of reported cases. This could partially be due
to the increasing number of caesarean sections, but also
because of increased awareness and widespread use of first
trimester ultrasound [3,4]. The risk increases with every
additional caesarean delivery, with 50% to 72% occurring in
women who had two or more caesarean deliveries. It is
thought that with every added caesarean section more
fibrosis occurs, enlarging the surface area of the scar and
leading to poor vascularity, which impairs wound healing
[13]. Most cases of CSP are diagnosed in first trimester by
transvaginal ultrasound. Possible symptoms can be abdom-
inal pain and vaginal blood loss, however, one third of
patients is asymptomatic [13]. Early recognition is important
because CSP can lead to severe complications such as uter-
ine rupture and serious haemorrhage, needing hysterec-
tomy with high maternal morbidity and loss of fertility
[4,13]. Differential diagnosis includes cervical pregnancy
and imminent spontaneous abortion [4–6]. Magnetic reson-
ance imaging may be used when ultrasound is inconclusive
[13]. Multiple treatment options for CSP have been
described, such as surgical treatment, medical treatment,
uterine artery embolization and curettage with or without
simultaneous cervical cerclage. Because the condition is so
rare, there are no universal guidelines and there is no con-
sensus of the preferred mode of treatment. At least, first tri-
mester termination of pregnancy is recommended to
prevent serious complications and lower the risk of hyster-
ectomy [5,13].
In our case, surgical evacuation through an open pro-
cedure was performed. This choice was made because of
the size of the pregnancy and the risk of haemorrhage.
Although serious haemorrhage occurred (total blood loss
1500mL), there was no need to perform a hysterectomy.
Conclusion
Unintended pregnancies in women using a LNG-IUD are
frequently ectopic pregnancies with a preponderance to
nidate outside the fallopian tube. Therefore, early diagnosis
and location of the pregnancy in women using a LNG-IUD
is essential.
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Figure 1. Transvaginal ultrasound six weeks post-surgery showed hardly any
remaining dehiscence of the uterine scar.
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